Spearhead Capital Advisors’s Ultragenyx Pharmaceutical RARE Stock Holding History

Spearhead Capital Advisors’s Portfolio RARE Stock Details RARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell
2022 Q2	$252K	Sell
2022 Q1	$312K	Buy
2021 Q4	$329K	Buy
2021 Q3	$318K	Buy
2021 Q2	$316K	Buy
2021 Q1	$315K	Buy